These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. GM1 locates to mature amyloid structures implicating a prominent role for glycolipid-protein interactions in Alzheimer pathology. Michno W; Wehrli PM; Zetterberg H; Blennow K; Hanrieder J Biochim Biophys Acta Proteins Proteom; 2019 May; 1867(5):458-467. PubMed ID: 30273679 [TBL] [Abstract][Full Text] [Related]
8. Distinct deposition of amyloid-β species in brains with Alzheimer's disease pathology visualized with MALDI imaging mass spectrometry. Kakuda N; Miyasaka T; Iwasaki N; Nirasawa T; Wada-Kakuda S; Takahashi-Fujigasaki J; Murayama S; Ihara Y; Ikegawa M Acta Neuropathol Commun; 2017 Oct; 5(1):73. PubMed ID: 29037261 [TBL] [Abstract][Full Text] [Related]
9. Structural amyloid plaque polymorphism is associated with distinct lipid accumulations revealed by trapped ion mobility mass spectrometry imaging. Michno W; Wehrli PM; Koutarapu S; Marsching C; Minta K; Ge J; Meyer SW; Zetterberg H; Blennow K; Henkel C; Oetjen J; Hopf C; Hanrieder J J Neurochem; 2022 Feb; 160(4):482-498. PubMed ID: 34882796 [TBL] [Abstract][Full Text] [Related]
10. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain. Güntert A; Döbeli H; Bohrmann B Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022 [TBL] [Abstract][Full Text] [Related]
11. Shedding Light on the Molecular Pathology of Amyloid Plaques in Transgenic Alzheimer's Disease Mice Using Multimodal MALDI Imaging Mass Spectrometry. Kaya I; Zetterberg H; Blennow K; Hanrieder J ACS Chem Neurosci; 2018 Jul; 9(7):1802-1817. PubMed ID: 29648443 [TBL] [Abstract][Full Text] [Related]
12. Chemical traits of cerebral amyloid angiopathy in familial British-, Danish-, and non-Alzheimer's dementias. Michno W; Koutarapu S; Camacho R; Toomey C; Stringer K; Minta K; Ge J; Jha D; Fernandez-Rodriguez J; Brinkmalm G; Zetterberg H; Blennow K; Ryan NS; Lashley T; Hanrieder J J Neurochem; 2022 Nov; 163(3):233-246. PubMed ID: 36102248 [TBL] [Abstract][Full Text] [Related]
13. Mass Spectrometry Imaging in Alzheimer's Disease. Ikegawa M; Kakuda N; Miyasaka T; Toyama Y; Nirasawa T; Minta K; Hanrieder J Brain Connect; 2023 Aug; 13(6):319-333. PubMed ID: 36905365 [No Abstract] [Full Text] [Related]
14. Diversity in Aβ deposit morphology and secondary proteome insolubility across models of Alzheimer-type amyloidosis. Xu G; Fromholt SE; Chakrabarty P; Zhu F; Liu X; Pace MC; Koh J; Golde TE; Levites Y; Lewis J; Borchelt DR Acta Neuropathol Commun; 2020 Apr; 8(1):43. PubMed ID: 32252825 [TBL] [Abstract][Full Text] [Related]
15. Correlative Chemical Imaging Identifies Amyloid Peptide Signatures of Neuritic Plaques and Dystrophy in Human Sporadic Alzheimer's Disease. Koutarapu S; Ge J; Jha D; Blennow K; Zetterberg H; Lashley T; Michno W; Hanrieder J Brain Connect; 2023 Jun; 13(5):297-306. PubMed ID: 36074939 [No Abstract] [Full Text] [Related]
16. Diversity of senile plaques in Alzheimer's disease as revealed by a new monoclonal antibody that recognizes an internal sequence of the Abeta peptide. Rábano A; Jiménez-Huete A; Acevedo B; Calero M; Ghiso J; Valdés I; Gavilondo J; Frangione B; Méndez E Curr Alzheimer Res; 2005 Oct; 2(4):409-17. PubMed ID: 16248846 [TBL] [Abstract][Full Text] [Related]